Ming-hui G. Zhao

Pr
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 612 publications

Bortezomib-Cyclophosphamide-Dexamethasone versus Rituximab in PGNMID.

Bortezomib-Cyclophosphamide-Dexamethasone versus Rituximab in PGNMID -Dexamethasone versus Rituximab in PGNMID.

Anti-PLA2R antibodies promote endothelial pyroptosis and a procoagulant phenotype through FcγRI signaling.

Clinical phenotype and prognosis of Patients with Diabetic Kidney Disease complicated by a Primary Podocytopathy.

Showing 1-12 of 612

Last Updated: 09/26/2026